AI assistant
Azelis Group NV Board/Management Information 2024
3909_rns_2024-05-08_50d2fa11-f58b-42c5-9ecb-52e2ee74ee71.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Biography of Kåre Schultz
Kåre Schultz
Kåre Schultz served as President and CEO of Teva Pharmaceutical Industries from 2017 until his retirement in 2023. Previously, Mr. Schultz served as President and Chief Executive Officer for H. Lundbeck A/S and worked for a large part of his career at Novo Nordisk, serving in numerous leadership roles. Mr. Schultz has been a member of several boards, including International Flavor and Fragrances and Royal Unibrew A/S, and is currently serving as Chairman of the Board for two non-listed companies, Bespak and Karo Healthcare.
Mr. Schultz holds a master's degree in economics from the University of Copenhagen.
